TCL Archive GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer. November 2, 2007
TCL Archive Cancer Care Cost To Jump by 27 Percent In a Decade, Reaching $158 Billion in 2020 January 28, 2011
TCL Archive NCAB Votes Down Effort to Delay CCOP RFA, Directs Subcommittee To Look Again A Program Components February 12, 1982
TCL Archive Republican Contenders Slam FDA Decision In Care Of Boy With Treatable Brain Tumor. February 4, 2000
TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
